Navigation Links
Entelos Expands Executive Team
Date:2/5/2013

San Mateo, CA (PRWEB) February 05, 2013

Entelos Holding Corp. (“Entelos” or the “Company”), a premier provider of physiological system modeling and services that help pharmaceutical and consumer product companies predict better paths to success in their development process, today announced that Dr. Mike Davies and Dr. Dominic John have joined the senior management team of the Company as Global Vice President of Sales and Vice President of Marketing, effective immediately.

“It is an indication of the opportunity ahead that we have been able to attract such seasoned and experienced executives who will, in turn, help us execute on the opportunity.” said Shawn O’Connor, President and Chief Executive Officer of Entelos. “With more and more companies looking to project efficient outcomes, study less and outsource more, Entelos is ideally placed to address the market need with leading modeling technology, physiological models and experienced scientific services. Mike and Dominic both bring to Entelos over 35 years of experience leading successful scientific companies in our market space. Their contributions will be invaluable to our future investment and growth to deliver market leading strategic partnerships and predictive therapeutic solutions.”

Dr. Davies has had more than 20 years of experience providing a robust background in scientific research and a track record of strong commercial leadership. Prior to joining Entelos, Dr. Davies was Vice President Global Sales of the Health Sciences GBU at Oracle Corporation after holding senior positions in Sales and Global Strategic Partnerships over 10 years at Phase Forward, Inc. and prior at Parke-Davis, a division of Warner Lambert. Dr. Davies scientific background is based in physiology and pharmacology having completed 3 years post-doctoral work at the University of Rochester.

Dr. John has had more than 15 years in research and scientific software product management and marketing having held senior positions in MDL Information Systems, Symyx Technologies and Accelrys Inc. Prior to joining Entelos, Dr. John was Director of Product Marketing at Accelrys, a $160M scientific software company. Dr. John has a scientific background that includes modeling, biochemistry and toxicology.

Entelos is a physiological modeling and simulation software and services company delivering predictive technologies reducing risk, time, and cost of product development for pharmaceutical, biotechnology, nutrition and consumer products companies. The Company's PhysioLab® systems biology models generate virtual drug and patient populations providing qualitative and quantitative insight and understanding to develop safer and more effective drugs and consumer products. Entelos’ understanding of population variability has significant application to the emerging field of personalized medicine and market segmentation. The Company is headquartered in San Mateo, California. For more information, please visit http://www.entelos.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10386823.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Blackall Mechanical, Inc. Expands Project Department to Better Serve Customers in North and South Texas
2. Popular Medical Tourism Portal, myMEDholiday.com, Expands Its Functionality by Adding RSS Feeds
3. Zinga Frozen Yogurt Expands Into Southern California in a Big Way
4. US Drug Watchdog Now Expands Their DePuy Pinnacle All Metal Hip Implant Initiative with Emphasis on Senior Citizens and Getting a Blood Test for Cobalt and Chromium
5. Henry Ford Expands Use of Apollo EPMM® to Provide Clinical Multimedia Management Solutions Enterprise-wide
6. Kitsilano Kitty's Closet Online Boutique Expands to Include Luxury Consignment!
7. Ambiance Expands Romantic Technology Leadership with New High-Tech Toy
8. Oncologist expands HPV research to anal cancer
9. Mesothelioma Victims Center Expands Its Best Mesothelioma Law Firms Get The Best Results Initiative Because Victims Of Mesothelioma Deserve The Best Results-Compensation
10. The Leader In Healthy Chocolate; Marketing Xocolate International Corporation (MXI Corp) Expands Their Operations To Hong Kong, Xocai Now Available On Five Continents
11. PayerFusion Expands Reach of Health Plan Administration Services Across the USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... , ... MelaKids, a Laredo-based company, has introduced a new concept for children’s ... gives us a full supply of melanin – in the back of the eye ... pigment; however, around the age of thirty, we develop a yellow-brown pigment in the ...
(Date:9/19/2017)... , ... September 19, 2017 , ... The Workgroup ... of health IT to create efficiencies in healthcare information exchange and a trusted advisor ... of their latest industry white paper, entitled Barriers to Adoption of the ERA ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the lack ... itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. Vitev ... alkaline water technologies, water filtration systems, and consumer education. , ...
(Date:9/19/2017)... ... September 19, 2017 , ... Bone Solutions Inc. (BSI), an ... orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with ... magnesium, a critical property for bone health and development. , “We’re excited to ...
(Date:9/19/2017)... ... September 19, 2017 , ... Ron Norman, CEO of Team Decades, ... of making a distinct rather than generic impression in the job market if one ... a stack of resumes knows that the first impression they give off is not ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Sept. 6, 2017   PDI , a leader in ... host an educational session focused on the role of ... prevention at the 2017 Annual Scientific Meeting of the ... place at the Phoenix Convention ... Sept. 16-19, will also feature PDI,s Prevantics® Device ...
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)... NEWTOWN, Pa. , Sept. 5, 2017  Xyntek Inc. has announced another ... opened a new Midwest office to meet the growing demands of customer engagements ... Xyntek's new Midwest office is located at ... ... demands of customer engagements regionally. ...
Breaking Medicine Technology: